Delivery Order 36C25222D0009-36C25225N0120
Award Date
12/1/24
Potential Completion Date
11/30/26
Potential Value
$30K
Federal Agency
Veterans Integrated Service Network 12
Awardee
Myriad Genetic Laboratories Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6632 - Analysis Instruments, Medical Laboratory Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration was granted to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide Prolaris prostate cancer testing services. The firm fixed price contract, valued at $14,994.00, is a Blanket Purchase Agreement (BPA) call to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network (VISN) 19 in Salt Lake...
This $122,672 federal contract was awarded by the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract is for the delivery of Prolaris prostate cancer testing services, which analyze genetic information to determine disease progression risks and support clinical treatment decisions. The contract was competitively awarded without a set-aside designation, and is structured...
This is a federal contract award from the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract is for the provision of Prolaris prostate cancer testing services to the VA's Salt Lake City VA Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $2,499. The contract has no set-aside designation. This BPA is part of a larger Indefinite Delivery Vehicle (IDV) awarded by the VA's...
This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600...
This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...
This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
This is a firm-fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Myriad Genetics Inc. for $589,712.00 to provide Prolaris genetic testing services to the VA Long Beach Healthcare System. The contract has a 1-year base period with two 1-year option periods, and is for performing quantitative PCR analysis on prostate biopsy samples to measure gene expression and generate clinical reports to assess prostate cancer aggressiveness and guide treatment. This contract...
This federal contract award to Myriad Genetics Inc. is for a Blanket Purchase Agreement (BPA) call valued at $100,000 to provide genetic testing services related to cancer diagnostics and risk assessment. The contract was awarded by the Defense Health Agency, a component of the Department of Defense, to deliver Myriad's Prolaris quantitative PCR testing on prostate biopsy samples. The Prolaris test helps assess tumor aggressiveness and guide treatment approaches for prostate cancer patients....